NCT03415997

Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight

Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight at Abdominal CT: a North American Randomized Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 239 (actual)
• Sponsor: Nova Scotia Health Authority · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight. Participants will be randomized into 2 groups based on contrast dosing technique, and solid organ enhancement at uniphasic abdominal CT will be measured.

Conditions

• Contrast Media Dosing

Interventions

Type	Name	Description
DRUG	Iohexol	Iodinated contrast media

Timeline

• Start date: 2018-02-21
• Primary completion: 2018-11-09
• Completion: 2018-11-09
• First posted: 2018-01-30
• Last updated: 2019-01-31

Locations

1 site across 1 country: Canada

Regulatory

• FDA-regulated drug study